Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2014 Nov 16;146:30–38. doi: 10.1016/j.drugalcdep.2014.10.027

Table 2.

Summary of models and number of outcomes in exposed case and control cohorts.

Figures Competing risks model

(covariates)
Exposure Outcomea Number of outcomes

Cases Controls
1a. Individual matching (sex, birth year) METH/AMPH PD 15 27
Females 8 6
Males 7 21
Case–only (birth year) Females vs. Males (see above)

1b. Individual matching (sex, birth year) METH/AMPH PD/PT 30 49
Females 18 18
Males 12 31
Case–only (birth year) Females vs. Males (see above)

2. Individual matching (sex, birth year) Cocaineb,c PD/PT 4 22
Case–only (sex, birth year) Cocaine vs. METH/AMPH PD/PT 4 vs. 30
Case–only (sex, birth year) METH/AMPH vs. cocaine PD/PT 30 vs. 4

3a.d Individual matching (sex, birth year) METH/AMPH PD>0 event time 12 27
Females 8 6
Males 4 21
Case–only (birth year) Females vs. Males (see above)

3b.d Individual matching (sex, birth year) METH/AMPH PD/PT>0 event time 22 49
Females 15 18
Males 7 31
Case–only (birth year) Females vs. Males (see above)
a

PD: ICD-9-CM 332.0 primary Parkinson's disease; PD/PT: ICD-9-CM 332.0, 332.1, 333.0 333.1.

b

All exposed cases had event times > 0; only one case had PD ICD-9 332.0.

c

Includes 3 female cases and one male case, 8 female and 14 male matched controls.

d

Figure is provided in an online supplement.